New to The Street Signs Pressure BioSciences, Inc. To 12 Month TV Series, Agreement Includes Commercials and Billboard Ads
June 01, 2023 10:00 ET
|
FMW Media Works Corp
NEW YORK, June 01, 2023 (GLOBE NEWSWIRE) -- FMW Media's business TV show, New to The Street, announces the signing of a 12-month contract for filming and broadcasting tailored interviews and...
New to The Street Signs Acurx Pharmaceuticals, Inc. to Additional Six-Month Media Contract with Iconic Billboard Ads and Commercial Support
March 23, 2023 16:00 ET
|
FMW Media Works Corp
NEW YORK, March 23, 2023 (GLOBE NEWSWIRE) -- FMW Media's business TV show, New to The Street, announces signing Acurx Pharmaceuticals, Inc. (NASDAQ: ACXP) ($ACXP) ("Acurx") to an additional...
BioNovelus, Inc. Announces Bob Eisiminger to Join Advisory Board
August 27, 2019 11:00 ET
|
BioNovelus, Inc.
POTOMAC, Md., Aug. 27, 2019 (GLOBE NEWSWIRE) -- BioNovelus, Inc. (OTC: ONOV) announces Bob Eisiminger has joined the Company’s newly created Advisory Board. BioNovelus’ Advisory Board seats...
BioNovelus Announces Removal of Yield Sign
August 13, 2019 09:00 ET
|
BioNovelus, Inc.
POTOMAC, Md., Aug. 13, 2019 (GLOBE NEWSWIRE) -- BioNovelus, Inc. (OTC: ONOV) announces it has submitted all necessary documentation, including its 2019 2Q report, to qualify as a “Pink Current”...
BioNovelus Announces Removal of Stop Sign
July 29, 2019 09:00 ET
|
BioNovelus, Inc.
POTOMAC, Md., July 29, 2019 (GLOBE NEWSWIRE) -- BioNovelus, Inc. (OTC: ONOV) announces it has submitted all necessary documentation to qualify as a “Limited Information” company on the OTC Markets. ...
BioNovelus, Inc. Announces Ian Gerrard as Head of Corporate Finance and Accounting
June 19, 2019 09:00 ET
|
BioNovelus, Inc.
SCOTTSDALE, Ariz., June 19, 2019 (GLOBE NEWSWIRE) -- BioNovelus, Inc. (ONOV: OTC) announces that it has retained Ian Gerrard as its new Head of Corporate Finance & Accounting. Mr. Gerrard has...
UPDATE - BioNovelus, Inc. Announces Acquisition of Bayberry Acquisition Corp., Hires Mark Fuller as New President and Chief Executive Officer
June 11, 2019 10:15 ET
|
BioNovelus, Inc.
SCOTTSDALE, Ariz., June 11, 2019 (GLOBE NEWSWIRE) -- BioNovelus, Inc. (ONOV: OTC) announces that it has closed its acquisition of Bayberry Acquisition Corp. and hired Mark Fuller as its new...
BioNovelus, Inc. Announces Acquisition of Bayberry Acquisition Corp., Hires Mark Fuller as New President and Chief Executive Officer
June 11, 2019 09:00 ET
|
BioNovelus, Inc.
SCOTTSDALE, Ariz., June 11, 2019 (GLOBE NEWSWIRE) -- BioNovelus, Inc. (ONOV: OTC) announces that it has closed its acquisition of Bayberry Acquisition Corp. and hired Mark Fuller as its new...
Immune Therapeutics Clears Critical Regulatory Hurdle for Lodonal in Kenya
March 17, 2017 09:07 ET
|
Immune Therapeutics, Inc.
ORLANDO, Fla., March 17, 2017 (GLOBE NEWSWIRE) -- Immune Therapeutics, Inc. (OTCQB:IMUN), a clinical-stage biopharmaceutical company developing therapies for a range of conditions using Lodonal™,...
UPDATE -- Immune Therapeutics Issues Special Letter to Shareholders
January 30, 2017 10:48 ET
|
Immune Therapeutics, Inc.
Company Expects to Report Initial Revenues in First Half of 2017 and Achieve Profitability by Year-End Company to Host Investor Conference Call to Discuss Positive Developments ORLANDO, Fla.,...